PlainRecalls
FDA Drug Moderate Class II Terminated

Amethyst (Levonorgestrel and Ethinyl Estradiol Tablets USP, 90mcg/20mcg), 28 tablet dispenser (blister foil unit), Rx only, Manufactured by: Warner Chilcott Company, LLC Fajardo, Puerto Rico 00738: Distributed by: Actavis Pharma, Inc. Parsippany, NJ 07054 USA, NDC-52544-295-28

Reported: December 27, 2017 Initiated: November 20, 2017 #D-0125-2018

Product Description

Amethyst (Levonorgestrel and Ethinyl Estradiol Tablets USP, 90mcg/20mcg), 28 tablet dispenser (blister foil unit), Rx only, Manufactured by: Warner Chilcott Company, LLC Fajardo, Puerto Rico 00738: Distributed by: Actavis Pharma, Inc. Parsippany, NJ 07054 USA, NDC-52544-295-28

Reason for Recall

Labeling: Incorrect Instructions. "TABLETS IN WEEK 4 ARE INACTIVE" printed on the blister foil and package insert, however,all tablets are active.

Details

Recalling Firm
Teva Pharmaceuticals USA
Units Affected
5,374 blister cards/28 tablets
Distribution
Nationwide in the USA and Puerto Rico
Location
North Wales, PA

Frequently Asked Questions

What product was recalled?
Amethyst (Levonorgestrel and Ethinyl Estradiol Tablets USP, 90mcg/20mcg), 28 tablet dispenser (blister foil unit), Rx only, Manufactured by: Warner Chilcott Company, LLC Fajardo, Puerto Rico 00738: Distributed by: Actavis Pharma, Inc. Parsippany, NJ 07054 USA, NDC-52544-295-28. Recalled by Teva Pharmaceuticals USA. Units affected: 5,374 blister cards/28 tablets.
Why was this product recalled?
Labeling: Incorrect Instructions. "TABLETS IN WEEK 4 ARE INACTIVE" printed on the blister foil and package insert, however,all tablets are active.
Which agency issued this recall?
This recall was issued by the FDA Drug on December 27, 2017. Severity: Moderate. Recall number: D-0125-2018.